ArticleAsian Pacific journal of cancer prevention : APJCP2025
Genotype and Association of XRCC1 Gene With Liver Disease in Chronic Hcv Patients.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are well-established major risk factors for hepatocellular carcinoma (HCC). Nevertheless, only a minority of infected individuals progress to HCC in their lifetime, highlighting the potential influence of genetic factors in modulating susceptibility to this malignancy. The X-ray repair cross-complementing group (XRCC1) is involved in DNA repair pathways.
aiminvestigate the association between the c.24589 G>A single nucleotide polymorphism (SNP) of the XRCC1 gene and the risk of developing hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection.
methodsA case-control study was conducted in the oncology departments of Peshawar, Pakistan, involving 30 HCC patients and 30 cirrhotic HCV patients without HCC. After collecting relevant clinical data and basic laboratory tests,c.24589 G>A SNP of the XRCC1 gene was analyzed using the ARMS-PCR technique.
resultsA statistically significant higher frequency of XRCC1 (AA and GA) genotypes was observed in patients with hepatocellular carcinoma (HCC) compared to those with cirrhotic hepatitis C virus (HCV) (p = 0.0425). In addition, the A allele frequency was notably higher in the HCC group (54% compared to 23%, p = 0.0178). Moreover, multivariate analysis indicated that the c.24589 G>A SNP independently increased the risk of developing HCC by 4.58 times (95% CI: 1.7-11.88, p = 0.017). Furthermore, patients with the AA and GA genotypes displayed larger tumor sizes (p = 0.008), a greater number of tumor foci (p = 0.006), and higher Child-Pugh grades (p = 0.044).
conclusionXRCC1 gene polymorphism could be associated with increased risk of HCC development in chronic HCV patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.